ApprovalTrail

Company · Mississauga, Ontario, Canada

Mint Pharmaceuticals Inc

Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.

Drug products (DIN)
322
288 authorized now
Natural health products
0
0 active licences
Medical device licences
0
0 active
Notices of Compliance
416

Drug products

Authorized products first.

NameDINStatus
MINT-ABACAVIR02480956Marketed
MINT-ACITRETIN02468840Marketed
MINT-ACITRETIN02468859Marketed
MINT-ACYCLOVIR02524708Marketed
MINT-ACYCLOVIR02524716Marketed
MINT-ACYCLOVIR02524724Marketed
MINT-AMLODIPINE02362651Marketed
MINT-AMLODIPINE02362678Marketed
MINT-ANASTROZOLE02393573Marketed
MINT-APIXABAN02495430Marketed
MINT-APIXABAN02495449Marketed
MINT-ARIPIPRAZOLE02483556Marketed
MINT-ARIPIPRAZOLE02483564Marketed
MINT-ARIPIPRAZOLE02483572Marketed
MINT-ARIPIPRAZOLE02483580Marketed
MINT-ARIPIPRAZOLE02483599Marketed
MINT-ARIPIPRAZOLE02483602Marketed
MINT-ATENOL02368013Marketed
MINT-ATENOL02368021Marketed
MINT-ATENOL02368048Marketed
MINT-ATORVASTATIN02479508Marketed
MINT-ATORVASTATIN02479516Marketed
MINT-ATORVASTATIN02479524Marketed
MINT-ATORVASTATIN02479532Marketed
MINT-BETAHISTINE02538121Marketed
MINT-BETAHISTINE02538148Marketed
MINT-BETAHISTINE02538156Marketed
MINT-BISOPROLOL02465612Marketed
MINT-BISOPROLOL02465620Marketed
MINT-BUSPIRONE02519054Marketed
MINT-CANDESARTAN02476908Marketed
MINT-CANDESARTAN02476916Marketed
MINT-CANDESARTAN02476924Marketed
MINT-CANDESARTAN02476932Marketed
MINT-CAPECITABINE02508028Marketed
MINT-CARBAMAZEPINE02541238Marketed
MINT-CELECOXIB02412497Marketed
MINT-CELECOXIB02412500Marketed
MINT-CHLORTHALIDONE02557126Marketed
MINT-CHLORTHALIDONE02557134Marketed
MINT-CHLORTHALIDONE02557142Marketed
MINT-CIPROFLOX02423561Marketed
MINT-CITALOPRAM02429691Marketed
MINT-CITALOPRAM02429705Marketed
MINT-CITALOPRAM02429713Marketed
MINT-CLONIDINE02462192Marketed
MINT-CLONIDINE02462206Marketed
MINT-CLONIDINE02534738Marketed
MINT-CLOPIDOGREL02408910Marketed
MINT-DONEPEZIL02408600Marketed
MINT-DONEPEZIL02408619Marketed
MINT-DULOXETINE02438984Marketed
MINT-DULOXETINE02438992Marketed
MINT-DUTASTERIDE02428873Marketed
MINT-EMTRICITABINE/TENOFOVIR02521547Marketed
MINT-ENTACAPONE02535939Marketed
MINT-ENTECAVIR02485907Marketed
MINT-EPLERENONE02471442Marketed
MINT-EPLERENONE02471450Marketed
MINT-ESCITALOPRAM02407418Marketed
MINT-ESCITALOPRAM02407434Marketed
MINT-EZETIMIBE02423243Marketed
MINT-FAMOTIDINE02538628Marketed
MINT-FAMOTIDINE02538636Marketed
MINT-FINASTERIDE02389878Marketed
MINT-FINASTERIDE02537427Marketed
MINT-FLUOXETINE02380560Marketed
MINT-FLUOXETINE02380579Marketed
MINT-FROVATRIPTAN02509687Marketed
MINT-FUROSEMIDE02466759Marketed
MINT-FUROSEMIDE02466767Marketed
MINT-FUROSEMIDE02466775Marketed
MINT-GABAPENTIN02408880Marketed
MINT-GABAPENTIN02408899Marketed
MINT-GABAPENTIN02408902Marketed
MINT-GLICLAZIDE MR02423286Marketed
MINT-GLICLAZIDE MR02423294Marketed
MINT-HYDRALAZINE02468778Marketed
MINT-HYDRALAZINE02468786Marketed
MINT-HYDRALAZINE02468794Marketed
MINT-HYDROCHLOROTHIAZIDE02425947Marketed
MINT-HYDROCHLOROTHIAZIDE02426196Marketed
MINT-HYDROXYCHLOROQUINE02424991Marketed
MINT-IMATINIB02492334Marketed
MINT-IMATINIB02492342Marketed
MINT-INDOMETHACIN02461536Marketed
MINT-INDOMETHACIN02461811Marketed
MINT-IRBESARTAN02422980Marketed
MINT-IRBESARTAN02422999Marketed
MINT-IRBESARTAN02423006Marketed
MINT-ITRACONAZOLE02462559Marketed
MINT-KETOROLAC02461455Marketed
MINT-LACOSAMIDE02490544Marketed
MINT-LACOSAMIDE02490552Marketed
MINT-LACOSAMIDE02490560Marketed
MINT-LACOSAMIDE02490579Marketed
MINT-LETROZOLE02508109Marketed
MINT-LEUCOVORIN02496828Marketed
MINT-LEVETIRACETAM02442388Marketed
MINT-LEVETIRACETAM02442396Marketed
MINT-LEVETIRACETAM02442418Marketed
MINT-LEVETIRACETAM SOLUTION02558416Marketed
MINT-LEVOCARB02457954Marketed
MINT-LEVOCARB02457962Marketed
MINT-LOSARTAN02405733Marketed
MINT-LOSARTAN02405741Marketed
MINT-LOSARTAN02405768Marketed
MINT-LOSARTAN/HCTZ02389657Marketed
MINT-LOSARTAN/HCTZ02389665Marketed
MINT-LOSARTAN/HCTZ DS02389673Marketed
MINT-MEMANTINE02531887Marketed
MINT-METFORMIN02388766Marketed
MINT-METFORMIN02388774Marketed
MINT-METFORMIN XR02547309Marketed
MINT-METFORMIN XR02547317Marketed
MINT-METRONIDAZOLE02535807Marketed
MINT-MEXILETINE02536846Marketed
MINT-MEXILETINE02536854Marketed
MINT-MONTELUKAST02408627Marketed
MINT-MONTELUKAST02408635Marketed
MINT-MONTELUKAST02408643Marketed
MINT-NADOLOL02496380Marketed
MINT-NADOLOL02496399Marketed
MINT-OLANZAPINE02410141Marketed
MINT-OLANZAPINE02410168Marketed
MINT-OLANZAPINE02410176Marketed
MINT-OLANZAPINE02410184Marketed
MINT-OLANZAPINE02410192Marketed
MINT-OLANZAPINE ODT02436965Marketed
MINT-OLANZAPINE ODT02436973Marketed
MINT-OLANZAPINE ODT02436981Marketed
MINT-OLOPATADINE02422727Marketed
MINT-OLOPATADINE 0.2%02508605Marketed
MINT-ONDANSETRON02305259Marketed
MINT-ONDANSETRON02305267Marketed
MINT-ONDANSETRON ODT02487330Marketed
MINT-ONDANSETRON ODT02487349Marketed
MINT-ONDANSETRON SOLUTION02524090Marketed
MINT-OSELTAMIVIR02497441Marketed
MINT-OSELTAMIVIR02497476Marketed
MINT-PANTOPRAZOLE02417448Marketed
MINT-PAROXETINE02421372Marketed
MINT-PAROXETINE02421380Marketed
MINT-PAROXETINE02421399Marketed
MINT-PERINDOPRIL02476762Marketed
MINT-PERINDOPRIL02476770Marketed
MINT-PERINDOPRIL02476789Marketed
MINT-PIOGLITAZONE02326477Marketed
MINT-PIOGLITAZONE02326485Marketed
MINT-PIOGLITAZONE02326493Marketed
MINT-POSACONAZOLE02544644Marketed
MINT-PRAVASTATIN02317451Marketed
MINT-PRAVASTATIN02317478Marketed
MINT-PRAVASTATIN02317486Marketed
MINT-PREGABALIN02423804Marketed
MINT-PREGABALIN02423812Marketed
MINT-PREGABALIN02424185Marketed
MINT-PREGABALIN02424207Marketed
MINT-QUETIAPINE02438003Marketed
MINT-QUETIAPINE02438011Marketed
MINT-QUETIAPINE02438046Marketed
MINT-QUETIAPINE02438054Marketed
MINT-RAMIPRIL02421305Marketed
MINT-RAMIPRIL02421313Marketed
MINT-RAMIPRIL02421321Marketed
MINT-RANITIDINE02526379Marketed
MINT-RANITIDINE02526387Marketed
MINT-RISPERIDON02359790Marketed
MINT-RISPERIDON02359804Marketed
MINT-RISPERIDON02359812Marketed
MINT-RISPERIDON02359820Marketed
MINT-RISPERIDON02359839Marketed
MINT-RISPERIDON02359847Marketed
MINT-ROSUVASTATIN02397781Marketed
MINT-ROSUVASTATIN02397803Marketed
MINT-ROSUVASTATIN02397811Marketed
MINT-ROSUVASTATIN02397838Marketed
MINT-SERTRALINE02402378Marketed
MINT-SERTRALINE02402394Marketed
MINT-SERTRALINE02402408Marketed
MINT-SILDENAFIL02393069Marketed
MINT-SILDENAFIL02393077Marketed
MINT-SILDENAFIL02393085Marketed
MINT-SIMVASTATIN02372932Marketed
MINT-SIMVASTATIN02372940Marketed
MINT-SIMVASTATIN02372959Marketed
MINT-SIMVASTATIN02372967Marketed
MINT-SIMVASTATIN02372975Marketed
MINT-SITAGLIPTIN02553910Marketed
MINT-SITAGLIPTIN02553929Marketed
MINT-SITAGLIPTIN02553937Marketed
MINT-SPIRONOLACTONE02488140Marketed
MINT-SPIRONOLACTONE02488159Marketed
MINT-TADALAFIL02451670Marketed
MINT-TADALAFIL02451689Marketed
MINT-TADALAFIL02451697Marketed
MINT-TELMISARTAN02486369Marketed
MINT-TELMISARTAN02486377Marketed
MINT-TENOFOVIR02512939Marketed
MINT-TIZANIDINE02536765Marketed
MINT-TOLTERODINE02423308Marketed
MINT-TOLTERODINE02423316Marketed
MINT-TOPIRAMATE02315645Marketed
MINT-TOPIRAMATE02315653Marketed
MINT-TOPIRAMATE02315661Marketed
MINT-TRAMADOL/ACET02389800Marketed
MINT-TRIMEBUTINE02538202Marketed
MINT-TRIMEBUTINE02538210Marketed
MINT-VALGANCICLOVIR02495457Marketed
MINT-VARENICLINE02546949Marketed
MINT-VARENICLINE02546957Marketed
MINT-VARENICLINE02546965Marketed
MINT-ZOLMITRIPTAN02419521Marketed
MINT-ZOLPIDEM ODT02472821Marketed
MINT-ZOLPIDEM ODT02472848Marketed
MINT-ZOPICLONE02391716Marketed
MINT-ZOPICLONE02391724Marketed
MINT-ABACAVIR/LAMIVUDINE02497808Approved
MINT-ABIRATERONE02571439Approved
MINT-ABIRATERONE02571447Approved
MINT-ACYCLOVIR OINTMENT02560437Approved
MINT-ALENDRONATE02394855Approved
MINT-ALENDRONATE02394871Dormant
MINT-AMOXI/CLAV02513250Approved
MINT-AMOXI/CLAV02513269Approved
MINT-AMOXI/CLAV02513277Approved
MINT-APREMILAST02525747Dormant
MINT-BACLOFEN02542595Approved
MINT-BACLOFEN02542609Approved
MINT-BILASTINE02568772Approved
MINT-BRIVARACETAM02569612Approved
MINT-BRIVARACETAM02569620Approved
MINT-BRIVARACETAM02569639Approved
MINT-BRIVARACETAM02569647Approved
MINT-BRIVARACETAM02569655Approved
MINT-CAPECITABINE02508001Approved
MINT-CETIRIZINE02491125Dormant
MINT-CITALOPRAM SOLUTION02566125Approved
MINT-CLOPIDOGREL02408929Approved
MINT-DAPAGLIFLOZIN02559064Approved
MINT-DAPAGLIFLOZIN02559072Approved
MINT-DOXYCYCLINE02566966Approved
MINT-ESCITALOPRAM02407426Approved
MINT-GALANTAMINE ER02570939Approved
MINT-GALANTAMINE ER02570947Approved
MINT-GALANTAMINE ER02570955Approved
MINT-HYDROCHLOROTHIAZIDE02426218Dormant
MINT-ICATIBANT02524619Approved
MINT-LABETALOL02503255Approved
MINT-LABETALOL02503263Approved
MINT-LAMOTRIGINE02571544Approved
MINT-LAMOTRIGINE02571552Approved
MINT-LAMOTRIGINE02571560Approved
MINT-LATANOPROST02421127Approved
MINT-LATANOPROST/TIMOLOL02444666Approved
MINT-LEVOCARB02457970Dormant
MINT-LEVODOPA/BENSERAZIDE02572370Approved
MINT-LEVODOPA/BENSERAZIDE02572389Approved
MINT-LEVODOPA/BENSERAZIDE02572397Approved
MINT-OLANZAPINE02410206Approved
MINT-OLANZAPINE ODT02437007Dormant
MINT-OSELTAMIVIR02497468Approved
MINT-PANTOPRAZOLE02417421Approved
MINT-PREGABALIN02424193Approved
MINT-PREGABALIN02424215Approved
MINT-PREGABALIN02424223Approved
MINT-PREGABALIN02424231Approved
MINT-QUETIAPINE02438038Approved
MINT-QUETIAPINE XR02522187Dormant
MINT-QUETIAPINE XR02522195Dormant
MINT-QUETIAPINE XR02522209Dormant
MINT-QUETIAPINE XR02522217Dormant
MINT-QUETIAPINE XR02522225Dormant
MINT-RAMIPRIL02421291Approved
MINT-RAMIPRIL02421348Dormant
MINT-RASAGILINE02533723Approved
MINT-RASAGILINE02533731Approved
MINT-RIVAROXABAN02515237Approved
MINT-RIVAROXABAN02515245Approved
MINT-RIVAROXABAN02515253Approved
MINT-SILDENAFIL R02571358Approved
MINT-SITAGLIPTIN/METFORMIN02558874Approved
MINT-SITAGLIPTIN/METFORMIN02558882Approved
MINT-SITAGLIPTIN/METFORMIN02558890Approved
MINT-TADALAFIL02451662Approved
MINT-VENLAFAXINE XR02522977Dormant
MINT-VENLAFAXINE XR02522985Dormant
MINT-VENLAFAXINE XR02522993Dormant
MINT-ALENDRONATE02394863Cancelled Post Market
MINT-CEFPROZIL02317303Cancelled Post Market
MINT-CEFPROZIL02317311Cancelled Post Market
MINT-CIPROFLOX02423553Cancelled Post Market
MINT-CIPROFLOX02423588Cancelled Post Market
MINT-CIPROFLOXACIN02317427Cancelled Post Market
MINT-CIPROFLOXACIN02317435Cancelled Post Market
MINT-CIPROFLOXACIN02317443Cancelled Post Market
MINT-CITALOPRAM02304686Cancelled Post Market
MINT-CITALOPRAM02304694Cancelled Post Market
MINT-CITALOPRAM02370077Cancelled Post Market
MINT-DICLOFENAC02475197Cancelled Post Market

Showing 300 of 322 drug products. For the rest, search Health Canada’s database.

Notices of Compliance

Newest first.

  • MINT-LEVODOPA/BENSERAZIDEOctober 8, 2026 · NOC 38434 · Abbreviated New Drug Submission (ANDS)
  • MINT-CANDESARTANSeptember 24, 2026 · NOC 38359 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-BISOPROLOLSeptember 18, 2026 · NOC 38310 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-LAMOTRIGINESeptember 16, 2026 · NOC 38290 · Abbreviated New Drug Submission (ANDS)
  • MINT-VALGANCICLOVIRSeptember 15, 2026 · NOC 38289 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-ABIRATERONESeptember 11, 2026 · NOC 38275 · Abbreviated New Drug Submission (ANDS)
  • MINT-SILDENAFIL RSeptember 11, 2026 · NOC 38278 · Abbreviated New Drug Submission (ANDS)
  • MINT-LOSARTAN/HCTZ; MINT-LOSARTAN/HCTZ DSAugust 27, 2026 · NOC 38178 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-LOSARTANAugust 27, 2026 · NOC 38213 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-GALANTAMINE ERAugust 21, 2026 · NOC 38162 · Abbreviated New Drug Submission (ANDS)
  • MINT-TADALAFILAugust 12, 2026 · NOC 38108 · Abbreviated New Drug Submission (ANDS)
  • MINT-DULOXETINEJuly 30, 2026 · NOC 38014 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-TIZANIDINEJuly 29, 2026 · NOC 38007 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-IRBESARTANJuly 10, 2026 · NOC 37884 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-PIOGLITAZONEJuly 9, 2026 · NOC 37872 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-TOPIRAMATEJune 30, 2026 · NOC 37811 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-BRIVARACETAMJune 30, 2026 · NOC 37819 · Abbreviated New Drug Submission (ANDS)
  • MINT-LEVOCARBJune 23, 2026 · NOC 37750 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-BILASTINEJune 4, 2026 · NOC 37666 · Abbreviated New Drug Submission (ANDS)
  • MINT-DONEPEZILJune 3, 2026 · NOC 37659 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-ACITRETINMay 22, 2026 · NOC 37591 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-CAPECITABINEMay 20, 2026 · NOC 37593 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-IMATINIBApril 17, 2026 · NOC 37353 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-SPIRONOLACTONEApril 8, 2026 · NOC 37284 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-CITALOPRAMApril 1, 2026 · NOC 37231 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-CELECOXIBApril 1, 2026 · NOC 37239 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-HYDROXYCHLOROQUINEMarch 27, 2026 · NOC 37220 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-DOXYCYCLINEMarch 25, 2026 · NOC 37172 · Abbreviated New Drug Submission (ANDS)
  • MINT-FUROSEMIDEMarch 20, 2026 · NOC 37144 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-CITALOPRAM SOLUTIONFebruary 25, 2026 · NOC 36967 · New Drug Submission (NDS)
  • MINT-CANDESARTANFebruary 13, 2026 · NOC 36903 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-ZOPICLONEFebruary 4, 2026 · NOC 36851 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-HYDRALAZINEJanuary 6, 2026 · NOC 36685 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-IRBESARTANDecember 17, 2025 · NOC 36747 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-GABAPENTINDecember 9, 2025 · NOC 36558 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-ROSUVASTATINNovember 4, 2025 · NOC 36318 · Abbreviated New Drug Submission (ANDS)
  • MINT-ATORVASTATINOctober 27, 2025 · NOC 36315 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-ITRACONAZOLEOctober 27, 2025 · NOC 36369 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-CARBAMAZEPINESeptember 11, 2025 · NOC 35988 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-PERINDOPRILSeptember 2, 2025 · NOC 35939 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-ACYCLOVIR OINTMENTAugust 22, 2025 · NOC 35889 · Abbreviated New Drug Submission (ANDS)
  • MINT-PREGABALINAugust 6, 2025 · NOC 35797 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-DAPAGLIFLOZINJuly 7, 2025 · NOC 35633 · Abbreviated New Drug Submission (ANDS)
  • MINT-SITAGLIPTIN/METFORMINJune 27, 2025 · NOC 35593 · Abbreviated New Drug Submission (ANDS)
  • MINT-LEVETIRACETAM SOLUTIONJune 17, 2025 · NOC 35525 · Abbreviated New Drug Submission (ANDS)
  • MINT-HYDROXYCHLOROQUINEJune 13, 2025 · NOC 35518 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-APIXABANMay 27, 2025 · NOC 35417 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-ROSUVASTATINMay 22, 2025 · NOC 35399 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-CETIRIZINEMay 7, 2025 · NOC 35315 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-BETAHISTINEMay 6, 2025 · NOC 35307 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-EZETIMIBEMay 1, 2025 · NOC 35287 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-ANASTROZOLEApril 29, 2025 · NOC 35260 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-KETOROLACApril 4, 2025 · NOC 35130 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-LATANOPROSTFebruary 20, 2025 · NOC 34909 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-SILDENAFILJanuary 16, 2025 · NOC 34698 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-ZOLMITRIPTANJanuary 15, 2025 · NOC 34694 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-ZOLMITRIPTANDecember 18, 2024 · NOC 34576 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-AMOXI/CLAVDecember 13, 2024 · NOC 34551 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-SITAGLIPTINDecember 13, 2024 · NOC 34552 · Abbreviated New Drug Submission (ANDS)
  • MINT-CARBAMAZEPINENovember 28, 2024 · NOC 34457 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-BISOPROLOLNovember 28, 2024 · NOC 34468 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-RIVAROXABANOctober 18, 2024 · NOC 34271 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-ONDANSETRON ODTSeptember 23, 2024 · NOC 34088 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-ATENOLSeptember 20, 2024 · NOC 34058 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-ALENDRONATESeptember 3, 2024 · NOC 33925 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-ROSUVASTATINJuly 26, 2024 · NOC 33720 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-SILDENAFILJuly 24, 2024 · NOC 33707 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-MEXILETINEJuly 15, 2024 · NOC 33640 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-HYDROXYCHLOROQUINEJuly 12, 2024 · NOC 33665 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-FINASTERIDEJuly 9, 2024 · NOC 33597 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-FLUOXETINEJuly 5, 2024 · NOC 33643 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-LEVOCARBJuly 4, 2024 · NOC 33573 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-PREGABALINJuly 2, 2024 · NOC 33549 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-TOPIRAMATEJune 26, 2024 · NOC 33527 · Abbreviated New Drug Submission (ANDS)
  • MINT-FINASTERIDEJune 21, 2024 · NOC 33484 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-ACARBOSEJune 18, 2024 · NOC 33461 · Abbreviated New Drug Submission (ANDS)
  • MINT-AMOXI/CLAVJune 12, 2024 · NOC 33437 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-VENLAFAXINE XRMay 22, 2024 · NOC 33272 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-ITRACONAZOLEMay 9, 2024 · NOC 33196 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-GABAPENTINMay 3, 2024 · NOC 33198 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-METFORMIN XRApril 29, 2024 · NOC 33132 · Abbreviated New Drug Submission (ANDS)
  • MINT-VARENICLINEApril 10, 2024 · NOC 33033 · Abbreviated New Drug Submission (ANDS)
  • MINT-GLICLAZIDE MRApril 4, 2024 · NOC 33007 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-ESCITALOPRAMMarch 15, 2024 · NOC 32909 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-PRAVASTATINMarch 8, 2024 · NOC 32847 · Abbreviated New Drug Submission (ANDS)
  • MINT-LETROZOLEMarch 7, 2024 · NOC 32835 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-CITALOPRAMFebruary 29, 2024 · NOC 32823 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-SIMVASTATINFebruary 20, 2024 · NOC 32727 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-ROSUVASTATINJanuary 22, 2024 · NOC 32568 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-PANTOPRAZOLEJanuary 19, 2024 · NOC 32564 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-POSACONAZOLEJanuary 18, 2024 · NOC 32560 · Abbreviated New Drug Submission (ANDS)
  • MINT-OLOPATADINE 0.2%December 28, 2023 · NOC 32424 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-PERINDOPRILDecember 21, 2023 · NOC 32398 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-RIVAROXABANDecember 1, 2023 · NOC 32227 · Abbreviated New Drug Submission (ANDS)
  • MINT-RIVAROXABANDecember 1, 2023 · NOC 32231 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-TOPIRAMATEDecember 1, 2023 · NOC 32275 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-ABACAVIR/LAMIVUDINENovember 30, 2023 · NOC 32256 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-LEVETIRACETAMNovember 29, 2023 · NOC 32207 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-PAROXETINENovember 21, 2023 · NOC 32149 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MINT-IMATINIBNovember 20, 2023 · NOC 32142 · Supplement to an Abbreviated New Drug Submission (SANDS)

The latest 100 of 416.

Recalls and safety alerts that mention its products

Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.